1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62C2819528AC78C1000258577004553C3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?Searchview&Query=(Field%20ph=T%20and%20FIELD%20publishdate%20%3E=%201/11/2007)%20AND%20(the)%20and%20(field%20ItemCatalog=DB)&SearchWV=1&SearchFuzzy=1&SearchOrder=1&Start=21&Count=10
18
19Searchview&Query=(Field%20ph=T%20and%20FIELD%20publishdate%20%3E=%201/11/2007)%20AND%20(the)%20and%20(field%20ItemCatalog=DB)&SearchWV=1&SearchFuzzy=1&SearchOrder=1&Start=21&Count=10
2034.204.193.85
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Search Results

Results 21 - 30 of 456 Total Hits, .

    |    

DB Image

Disease State Awareness Programs for Orphan DrugsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics.

STUDY OVERVIEW Pharmaceutical companies use disease state awareness programs to raise awareness among consumers and healthcare practitioners about a... (ID 5301)
Companies Profiled: AstraZeneca, Alexion Pharmaceuticals, Bristol-Myers Squibb, Vertex Pharmaceuticals

$550.00

DB Image

Pharmaceutical Library Services: Financial & Staffing ResourcesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Pharmaceutical Library Services: Financial & Staffing Resources" STUDY OVERVIEW Wit... (ID 5250)
Companies Profiled: Abbvie, Biogen Idec, Boehringer Ingelheim, Celgene, more ...

DB Image

Nexavar Case Study: Using Publications and Presentations to Inform Practitioners and PatientsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-members: Click here to review a complimentary excerpt from "Nexavar Case Study: Using Publications and Presentations to Inform Practitioners and ... (ID 5057)
Companies Profiled: Bayer, Onyx Pharmaceuticals

DB Image

Erbitux Case Study: Using Congresses to Educate the Oncology CommunityDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Erbitux Case Study: Using Congresses to Educate the Oncology Community" STUDY OVERVI... (ID 5060)
Companies Profiled: Bristol-Myers Squibb, Eli Lilly and Company, Merck Serono, ImClone Systems Inc.

DB Image

Safety and Risk Management in the Pharmaceutical SectorDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to sign-up for a complimentary tour of "Safety and Risk Management in the Pharmaceutical Sector" STUDY OVERVIEW The pharmac... (ID 4998)
Companies Profiled: Alcon, Eli Lilly, United Therapeutics, Amgen, more ...

$250.00

DB Image

Nexium Case Study: Using PR To Reach Diverse Patient Populations and Build Bridges Between Product GenerationsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-members: Click here for a complimentary excerpt of Nexium Case Study: Using PR To Reach Diverse Patient Populations and Build Bridges Between Pr... (ID 5012)
Companies Profiled: AstraZeneca

DB Image

Patient Advocacy 2020: Structure, Effectiveness and Relationship Management Outside the United StatesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Patient Advocacy 2020: Structure, Effectiveness and Relationship Management Outside t... (ID 5588)
Companies Profiled: AbbVie, Astellas, Bayer, BioMarin, more ...

DB Image

Best Practices in the Management of Investigator Initiated Trials: Resource Allocation, Communication and Future ProspectsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Best Practices in the Management of Investigator Initiated Trials: Resource Allocatio... (ID 5615)
Companies Profiled: Alcon, Allergan, Arena Pharmaceuticals, Bayer, more ...

DB Image

Best Practices in the Management of Investigator Initiated Trials: Structure, Activities and ResponsibilitiesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Best Practices in the Management of Investigator Initiated Trials: Structure, Activit... (ID 5614)
Companies Profiled: Alcon, Allergan, Arena Pharmaceuticals, Bayer, more ...

DB Image

Raising Phase IV Performance & Value Through Optimal MSL Involvement: Objectives & Team StructureDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Raising Phase IV Performance & Value Through Optimal MSL Involvement: Objectives & Te... (ID 5585)
Companies Profiled: AbbVie, Alkermes, BeiGene, BioDelivery Sciences International, more ...